secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001437749-25-029457
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia closes $5.1M net equity offering with insider participation
---------------------------------------------------------------------

- Sold 4,800,000 shares of common stock and warrants for 4,800,000 shares at combined price of $1.25 per unit, raising $6M gross proceeds.
- Net proceeds expected to be approximately $5.1 million after deducting placement agent fees and expenses.
- Directors and executive officers purchased 734,400 shares/warrants, contributing $0.9M of gross proceeds.
- Warrants immediately exercisable at $1.25 per share, expiring September 20, 2027, with 4.99% beneficial ownership limitation.
- Company agreed to no additional equity issuance until Nov 18, 2025, and no variable rate transactions until Mar 19, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925029457/0001437749-25-029457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925029457/bcda20250919_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-029457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer